Extracellular Vesicles Enriched with Moonlighting Metalloproteinase Are Highly Transmissive, Pro-Tumorigenic, and Trans-Activates Cellular Communication Network Factor (

CCN2/CTGF CRISPR cellular communication network factor extracellular vesicles genome editing matrix metalloproteinase moonlighting metalloproteinase (MMP) oncosome protein moonlighting transcription factor

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
04 Apr 2020
Historique:
received: 19 02 2020
revised: 24 03 2020
accepted: 02 04 2020
entrez: 9 4 2020
pubmed: 9 4 2020
medline: 9 4 2020
Statut: epublish

Résumé

Matrix metalloproteinase 3 (MMP3) plays multiple roles in extracellular proteolysis as well as intracellular transcription, prompting a new definition of moonlighting metalloproteinase (MMP), according to a definition of protein moonlighting (or gene sharing), a phenomenon by which a protein can perform more than one function. Indeed, connective tissue growth factor (CTGF, aka cellular communication network factor 2 (CCN2)) is transcriptionally induced as well as cleaved by MMP3. Moreover, several members of the MMP family have been found within tumor-derived extracellular vesicles (EVs). We here investigated the roles of MMP3-rich EVs in tumor progression, molecular transmission, and gene regulation. EVs derived from a rapidly metastatic cancer cell line (LuM1) were enriched in MMP3 and a C-terminal half fragment of CCN2/CTGF. MMP3-rich, LuM1-derived EVs were disseminated to multiple organs through body fluid and were pro-tumorigenic in an allograft mouse model, which prompted us to define LuM1-EVs as oncosomes in the present study. Oncosome-derived MMP3 was transferred into recipient cell nuclei and thereby trans-activated the

Identifiants

pubmed: 32260433
pii: cancers12040881
doi: 10.3390/cancers12040881
pmc: PMC7226423
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP17K17895
Organisme : Japan Society for the Promotion of Science
ID : JP17K11642
Organisme : Japan Society for the Promotion of Science
ID : JP19H03817
Organisme : Japan Society for the Promotion of Science
ID : 19H04051
Organisme : Japan Society for the Promotion of Science
ID : JP17K11643
Organisme : Japan Society for the Promotion of Science
ID : 17K11669
Organisme : Japan Society for the Promotion of Science
ID : 18K09789
Organisme : Suzuken Memorial Foundation
ID : TE
Organisme : Ryobi Teien Memory Foundation
ID : KOk, CS, TE

Références

J Cell Biol. 2004 Dec 20;167(6):1231-40
pubmed: 15611341
J Bone Miner Res. 2006 Jul;21(7):1045-59
pubmed: 16813525
J Biol Chem. 1997 Jul 4;272(27):17216-22
pubmed: 9202045
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1267-1272
pubmed: 30017201
Biochimie. 2007 Mar;89(3):278-88
pubmed: 17291666
Oncology. 2001;61(4):315-22
pubmed: 11721179
Tissue Eng Part A. 2019 Oct;25(19-20):1413-1425
pubmed: 30734664
Cancer Lett. 2019 Sep 28;460:42-53
pubmed: 31233838
Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165731
pubmed: 32088316
Cancer Res. 1998 Oct 1;58(19):4468-74
pubmed: 9766680
J Biochem. 2001 Jul;130(1):79-87
pubmed: 11432783
Nat Rev Cancer. 2004 Nov;4(11):839-49
pubmed: 15516957
J Extracell Vesicles. 2016 Sep 27;5:33109
pubmed: 27680302
J Biochem. 1999 Jul;126(1):137-45
pubmed: 10393331
Liver Cancer. 2014 May;3(2):71-84
pubmed: 24944998
Int J Proteomics. 2012;2012:971907
pubmed: 22852084
Int J Mol Sci. 2019 Sep 17;20(18):
pubmed: 31533245
J Cell Biochem. 2018 Sep;119(9):7350-7362
pubmed: 29768689
Cytokine. 2017 Jan;89:82-90
pubmed: 27793525
Front Oncol. 2018 Oct 10;8:376
pubmed: 30364132
Methods Mol Biol. 2017;1489:177-185
pubmed: 27734377
Clin Cancer Res. 1999 Aug;5(8):1950-60
pubmed: 10473071
Genes Cancer. 2015 Nov;6(11-12):480-9
pubmed: 26807201
Oral Oncol. 2018 Nov;86:251-257
pubmed: 30409309
Front Biosci. 2008 May 01;13:5847-65
pubmed: 18508627
Cancer Sci. 2015 Dec;106(12):1669-77
pubmed: 26362844
Mol Cell Biol. 2008 Apr;28(7):2391-413
pubmed: 18172013
J Cell Biochem. 2018 Sep;119(9):7363-7376
pubmed: 29761931
Carcinogenesis. 2002 May;23(5):769-76
pubmed: 12016149
PLoS One. 2018 Feb 7;13(2):e0191109
pubmed: 29415026
Methods Mol Biol. 2017;1489:1-8
pubmed: 27734360
Cancers (Basel). 2019 Jun 08;11(6):
pubmed: 31181782
Nature. 2005 Jul 7;436(7047):123-7
pubmed: 16001073
J Biol Chem. 2018 Nov 16;293(46):17953-17970
pubmed: 30262666
J Biol Chem. 2002 Sep 27;277(39):36288-95
pubmed: 12114504
Biochem Biophys Res Commun. 2017 Dec 2;493(4):1478-1484
pubmed: 28986261
Jpn J Cancer Res. 1996 Jan;87(1):78-85
pubmed: 8609053
Oncotarget. 2015 Jan 20;6(2):715-31
pubmed: 25596732
Cancer Immunol Immunother. 2004 Mar;53(3):148-52
pubmed: 14730399
Biochem Biophys Res Commun. 2002 Jul 12;295(2):445-51
pubmed: 12150969
Nat Commun. 2017 Mar 06;8:14470
pubmed: 28262727
Oncoimmunology. 2015 Oct 29;5(3):e1091146
pubmed: 27141350
Mol Cancer. 2019 Dec 3;18(1):175
pubmed: 31796058
Biochem Biophys Res Commun. 2003 Apr 25;304(1):107-12
pubmed: 12705892
Eur J Immunol. 2003 Sep;33(9):2479-89
pubmed: 12938224
Sci Rep. 2016 Sep 08;6:32301
pubmed: 27604151
Cancer Sci. 2017 May;108(5):897-909
pubmed: 28208216
PLoS One. 2013;8(3):e58796
pubmed: 23533592
Cancers (Basel). 2020 Feb 24;12(2):
pubmed: 32102440
Cancer Res. 2009 Jul 15;69(14):5627-9
pubmed: 19584271
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Mol Cell Proteomics. 2018 Mar;17(3):495-515
pubmed: 29242380
Breast Cancer Res Treat. 2018 Jul;170(2):235-250
pubmed: 29557524
J Cell Commun Signal. 2016 Sep;10(3):223-227
pubmed: 27613407
Nat Cell Biol. 2008 May;10(5):619-24
pubmed: 18425114
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
Clin Sci (Lond). 2015 Feb;128(3):181-96
pubmed: 25294165
J Endocrinol. 2004 Jan;180(1):193-201
pubmed: 14709158
J Cell Biochem. 2017 Jan;118(1):43-51
pubmed: 27206651
Cancer Res. 2018 Sep 1;78(17):4902-4914
pubmed: 29967264
Sci Rep. 2017 Aug 22;7(1):9065
pubmed: 28831065
Oncotarget. 2017 Jun 27;8(47):81880-81891
pubmed: 29137230
Int J Cancer. 2015 Aug 1;137(3):504-11
pubmed: 24832082
J Cell Sci. 2018 Aug 3;131(15):
pubmed: 30076240
Cells. 2020 Mar 19;9(3):
pubmed: 32204513
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394
J Biol Chem. 2015 Sep 4;290(36):21976-84
pubmed: 26183781
BMC Cancer. 2019 Jun 14;19(1):581
pubmed: 31200666

Auteurs

Yuka Okusha (Y)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Division of Molecular and Cellular Biology, Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Takanori Eguchi (T)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Advanced Research Center for Oral and Craniofacial Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.

Manh T Tran (MT)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.

Chiharu Sogawa (C)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.

Kaya Yoshida (K)

Department of Oral Healthcare Education, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8504, Japan.

Mami Itagaki (M)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Research program for undergraduate students, Okayama University Dental School, Okayama 700-8525, Japan.

Eman A Taha (EA)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan.
Department of Biochemistry, Ain Shams University Faculty of Science, Cairo 11566, Egypt.

Kisho Ono (K)

Department of Oral and Maxillofacial Surgery, Okayama University Hospital, Okayama 700-0914, Japan.

Eriko Aoyama (E)

Advanced Research Center for Oral and Craniofacial Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.

Hirohiko Okamura (H)

Department of Oral Morphology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama 700-8525, Japan.

Ken-Ichi Kozaki (KI)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.

Stuart K Calderwood (SK)

Division of Molecular and Cellular Biology, Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Masaharu Takigawa (M)

Advanced Research Center for Oral and Craniofacial Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.

Kuniaki Okamoto (K)

Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.

Classifications MeSH